Related Experiment Video
Updated: Aug 23, 2025

13:45
Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
10.0K
Current In Vitro and In Vivo Models to Study MCPyV-Associated MCC
Amanda S W Loke1, Paul F Lambert1, Megan E Spurgeon1
1McArdle Laboratory for Cancer Research, Department of Oncology, School of Medicine & Public Health, University of Wisconsin, Madison, WI 53705, USA.
Viruses
|October 27, 2022
Summary
Merkel cell polyomavirus (MCPyV) causes Merkel cell carcinoma (MCC). This review details MCPyV
Area of Science:
- Oncology
- Virology
- Dermatology
Background:
- Merkel cell polyomavirus (MCPyV) is the sole human polyomavirus linked to cancer.
- MCPyV is implicated in over 80% of Merkel cell carcinoma (MCC) cases.
- Viral T antigens drive oncogenesis in MCPyV-positive MCC.
Purpose of the Study:
- To review the current understanding of MCPyV and its role in MCC.
- To summarize existing in vitro and in vivo model systems for studying MCPyV-driven carcinogenesis.
- To identify challenges and future directions in MCC modeling.
Main Methods:
- Literature review of MCPyV and MCC research.
- Analysis of current in vitro and in vivo model systems.
- Discussion of viral T antigen functions in neoplasia.
Main Results:
- MCPyV integration leads to expression of viral small T (ST) and truncated large T antigens.
- Model systems are advancing the characterization of MCPyV oncogenesis.
- Understanding viral T antigen function is key to MCC development.
Conclusions:
- MCPyV is a critical etiological factor in MCC.
- Advanced model systems are crucial for studying MCPyV-induced cancer.
- Further research is needed to address remaining challenges in MCC modeling.

